Dixon Technologies engaged with institutional investors and analysts on July 7, 2026. The interaction was conducted pursuant to Regulations 30 and 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that no unpublished price sensitive information was shared during this session and no presentation was made.

The meeting was held to engage with key market participants, including advisors and investors. The interaction took place through virtual mode, covering a one-on-one discussion.

Meeting Details

The following table provides the specifics of the meeting held on July 7, 2026:

The intimation was filed by Ashish Kumar, President- Chief Legal Counsel & Group Company Secretary of Dixon Technologies. The disclosure was submitted to both BSE Limited and National Stock Exchange of India Limited to ensure compliance with regulatory requirements.

Investec has maintained its Buy rating on Dixon Technologies while raising its target price to ₹16,200, up from the earlier target of ₹14,500. The revision is accompanied by an upward revision of 6–8% in FY27–28 EPS estimates, reflecting a more optimistic outlook on the company's mobile business, market-share dynamics, and diversified electronics manufacturing growth drivers.

Revised Rating and Key Parameters

The updated investment thesis reflects several positive developments across Dixon Technologies' business segments. The table below captures the key parameters of Investec's revised stance:

Mobile Segment: Stabilisation and Market-Share Gains

Investec's revised estimates are underpinned by stabilising mobile sales, with the brokerage expressing confidence in sustained manufacturing output for FY27. A notable additional driver is the potential for market-share gains from Chinese EMS players, which could provide Dixon Technologies with incremental volume opportunities. The Vivo joint venture continues to represent a meaningful upside, with potential volumes exceeding 20 million units, further strengthening the company's position within India's expanding mobile manufacturing ecosystem.

Near-Term EBITDA Outlook and H2 Recovery

Despite the expiry of PLI (Production Linked Incentive) benefits, Investec expects H1 FY27 EBITDA to remain flat, suggesting resilience in the company's core operations. This is anticipated to be followed by strong earnings growth in H2 FY27, driven by a combination of volume ramp-ups, improved product mix, and operational efficiencies. The brokerage also highlights additional upside potential from mobile exports, which are seen as a growing contributor to revenue diversification.

IT Hardware, Telecom, and Specialty EMS

Higher revenue estimates for telecom and IT hardware segments form another key pillar of the upgraded outlook. These segments reflect Dixon Technologies' broadening product portfolio and its increasing relevance across multiple electronics manufacturing verticals. On the margin front, Investec anticipates gains beginning FY28, driven by backward integration initiatives. The company's strategy of expanding into high-margin specialty EMS through acquisitions is viewed as a significant long-term value driver, enabling Dixon Technologies to move up the value chain within the electronics manufacturing services space.

Summary of Growth Drivers

The key factors underpinning Investec's maintained Buy recommendation and revised target price on Dixon Technologies are:

• Stabilising mobile sales with visibility on sustained FY27 manufacturing output
• Market-share gains from Chinese EMS players offering incremental volume upside
• Vivo JV potential offering 20m+ unit volume upside
• Mobile exports contributing to additional revenue diversification
• Higher telecom and IT hardware revenue estimates across the product portfolio
• Flat H1 FY27 EBITDA despite PLI expiry, followed by strong H2 earnings growth
• Backward integration expected to deliver margin gains from FY28
• Specialty EMS expansion via acquisitions targeting higher-margin business segments